Core Insights - JD Health has publicly unveiled its latest achievements in building a smart interconnected ecosystem for medical devices, establishing an alliance represented by CGM dynamic blood glucose monitors and AI models [1] - The CGM market has seen significant growth, with JD's CGM category transaction value increasing by over 90% year-on-year since 2025 [2] - The healthcare device industry in China is experiencing rapid growth driven by both policy and market demands, shifting consumer health management from passive treatment to proactive prevention [1][2] Group 1 - JD Health has launched a comprehensive smart blood glucose management system that integrates monitoring, analysis, intervention, and tracking through its AI health assistant "KangKang Blood Sugar" [1][2] - The CGM devices are compact and allow for continuous monitoring over several days, significantly reducing the discomfort associated with traditional blood sampling methods [2] - JD Health plans to expand its health management ecosystem to include other chronic disease areas such as blood pressure, electrocardiograms, and respiratory health [1][3] Group 2 - The company collaborates with brands like Yuyue, Sanofi, and Weitai to offer customized CGM products that provide real-time blood sugar monitoring and alerts through the JD Health app [2] - JD Health leverages its nationwide network of top-tier hospital doctors and various professional services to provide tailored health advice based on comprehensive user data [3] - Future plans include deepening the integration of "medical devices + AI" in health management scenarios, enhancing accessibility to quality healthcare services [3]